1|Page
,2|Page
Principles of Pharmacology:
Comprehensive Final Exam
Q1. A patient requires a rapid onset of action for a medication during an emergency.
Which route of administration bypasses absorption entirely?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
Rationale: Intravenous administration injects the drug directly into the systemic
circulation, meaning absorption is skipped completely and bioavailability is 100%.
Q2. Which pharmacokinetic process is most heavily altered in a patient with end-
stage liver disease?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Rationale: The liver is the primary organ responsible for drug biotransformation and
metabolism via cytochrome P450 enzymes.
Q3. What term describes the ratio of the toxic dose of a drug to its therapeutically
effective dose?
A) Bioavailability
B) Therapeutic index
C) Clearance rate
D) Efficacy coefficient
Rationale: The therapeutic index measures drug safety; a narrow index means the
margin between an effective dose and a toxic dose is very small.
Q4. An antagonist that binds to the same receptor site as an agonist and can be
overcome by increasing the agonist concentration is called what?
A) Competitive antagonist
B) Irreversible antagonist
C) Allosteric antagonist
D) Functional antagonist
Rationale: Competitive antagonists bind reversibly to the active site, meaning higher
levels of the agonist can displace them and restore the maximum response.
Q5. Which cellular receptor type utilizes G-proteins to initiate an intracellular
secondary messenger cascade?
A) Ligand-gated ion channel
B) Voltage-gated channel
C) Intracellular nuclear receptor
D) Metabotropic receptor
Rationale: G-protein-coupled receptors (GPCRs), or metabotropic receptors, trigger
secondary messengers like cAMP or IP3 when activated.
,3|Page
Q6. A patient is taking a drug with a high first-pass effect. How does this property
affect the drug's oral bioavailability?
A) It increases bioavailability
B) It decreases bioavailability
C) It has no effect on bioavailability
D) It delays absorption time only
Rationale: A high first-pass effect means a significant fraction of the oral drug is
metabolized by the liver before it ever reaches systemic circulation.
Q7. What is the primary plasma protein that binds to acidic drugs in the
bloodstream?
A) Alpha-1 acid glycoprotein
B) Beta-globulin
C) Albumin
D) Gamma-globulin
Rationale: Albumin is the most abundant plasma protein and primarily binds to acidic
drugs, while alpha-1 acid glycoprotein binds basic drugs.
Q8. If a drug has a half-life of 6 hours, how long will it take to reach steady-state
concentration during a continuous infusion?
A) 6 hours
B) 12 hours
C) 24 to 30 hours
D) 48 to 60 hours
Rationale: It takes approximately 4 to 5 half-lives to reach steady-state concentration
(4 x 6 = 24 hours; 5 x 6 = 30 hours).
Q9. Which parameter determines the loading dose of a drug needed to achieve a
target plasma concentration immediately?
A) Clearance
B) Volume of distribution
C) Half-life
D) Elimination rate constant
Rationale: Loading dose is directly calculated using the target plasma concentration
multiplied by the volume of distribution.
Q10. What type of reaction occurs during Phase II drug metabolism?
A) Oxidation
B) Reduction
C) Hydrolysis
D) Conjugation
Rationale: Phase I involves oxidation, reduction, and hydrolysis. Phase II involves
conjugation reactions like glucuronidation to make the drug more polar for excretion.
Q11. Stimulation of alpha-1 adrenergic receptors results in which physiological
action?
A) Bronchodilation
B) Vasoconstriction
C) Bradycardia
D) Increased GI motility
Rationale: Alpha-1 receptors are located on vascular smooth muscle, and their
activation leads to smooth muscle contraction and vasoconstriction.
, 4|Page
Q12. Which drug acts as a selective beta-1 adrenergic antagonist?
A) Propanolol
B) Metoprolol
C) Albuterol
D) Labatalol
Rationale: Metoprolol is a cardioselective beta-blocker that targets beta-1 receptors
primarily found in heart tissue.
Q13. What is the mechanism of action of pilocarpine?
A) Acetylcholinesterase inhibitor
B) Direct muscarinic agonist
C) Nicotinic antagonist
D) Adrenergic agonist
Rationale: Pilocarpine directly stimulates muscarinic acetylcholine receptors,
commonly used to lower intraocular pressure in glaucoma.
Q14. Activation of which receptor subtype is responsible for albuterol-induced
bronchodilation?
A) Alpha-2
B) Beta-1
C) Beta-2
D) Muscarinic-3
Rationale: Beta-2 adrenergic receptors relax smooth muscle in the airways, making
agonists highly effective for asthma.
Q15. What severe adverse effect can occur if a patient taking an MAO inhibitor
consumes foods rich in tyramine?
A) Profound hypotension
B) Hypertensive crisis
C) Respiratory depression
D) Hemolytic anemia
Rationale: Tyramine displaces norepinephrine into synaptic clefts; when MAO is
inhibited, this causes massive sympathetic stimulation and life-threatening
hypertension.
Q16. Which toxic regular effect is associated with an overdose of atropine?
A) Excessive salivation
B) Pupillary constriction
C) Diarrhea
D) Urinary retention
Rationale: Atropine is an anticholinergic block. It shuts down parasympathetic
actions, leading to dry mouth, blurry vision, tachycardia, and urinary retention.
Q17. What is the drug of choice to manage an acute anaphylactic shock reaction?
A) Norepinephrine
B) Epinephrine
C) Dopamine
D) Isoproterenol
Rationale: Epinephrine acts on alpha-1 (vasoconstriction), beta-1 (cardiac output),
and beta-2 (bronchodilation) receptors, reversing all major features of anaphylaxis.
Q18. What is the mechanism of action of physostigmine?
A) Reversible acetylcholinesterase inhibitor
,2|Page
Principles of Pharmacology:
Comprehensive Final Exam
Q1. A patient requires a rapid onset of action for a medication during an emergency.
Which route of administration bypasses absorption entirely?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
Rationale: Intravenous administration injects the drug directly into the systemic
circulation, meaning absorption is skipped completely and bioavailability is 100%.
Q2. Which pharmacokinetic process is most heavily altered in a patient with end-
stage liver disease?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Rationale: The liver is the primary organ responsible for drug biotransformation and
metabolism via cytochrome P450 enzymes.
Q3. What term describes the ratio of the toxic dose of a drug to its therapeutically
effective dose?
A) Bioavailability
B) Therapeutic index
C) Clearance rate
D) Efficacy coefficient
Rationale: The therapeutic index measures drug safety; a narrow index means the
margin between an effective dose and a toxic dose is very small.
Q4. An antagonist that binds to the same receptor site as an agonist and can be
overcome by increasing the agonist concentration is called what?
A) Competitive antagonist
B) Irreversible antagonist
C) Allosteric antagonist
D) Functional antagonist
Rationale: Competitive antagonists bind reversibly to the active site, meaning higher
levels of the agonist can displace them and restore the maximum response.
Q5. Which cellular receptor type utilizes G-proteins to initiate an intracellular
secondary messenger cascade?
A) Ligand-gated ion channel
B) Voltage-gated channel
C) Intracellular nuclear receptor
D) Metabotropic receptor
Rationale: G-protein-coupled receptors (GPCRs), or metabotropic receptors, trigger
secondary messengers like cAMP or IP3 when activated.
,3|Page
Q6. A patient is taking a drug with a high first-pass effect. How does this property
affect the drug's oral bioavailability?
A) It increases bioavailability
B) It decreases bioavailability
C) It has no effect on bioavailability
D) It delays absorption time only
Rationale: A high first-pass effect means a significant fraction of the oral drug is
metabolized by the liver before it ever reaches systemic circulation.
Q7. What is the primary plasma protein that binds to acidic drugs in the
bloodstream?
A) Alpha-1 acid glycoprotein
B) Beta-globulin
C) Albumin
D) Gamma-globulin
Rationale: Albumin is the most abundant plasma protein and primarily binds to acidic
drugs, while alpha-1 acid glycoprotein binds basic drugs.
Q8. If a drug has a half-life of 6 hours, how long will it take to reach steady-state
concentration during a continuous infusion?
A) 6 hours
B) 12 hours
C) 24 to 30 hours
D) 48 to 60 hours
Rationale: It takes approximately 4 to 5 half-lives to reach steady-state concentration
(4 x 6 = 24 hours; 5 x 6 = 30 hours).
Q9. Which parameter determines the loading dose of a drug needed to achieve a
target plasma concentration immediately?
A) Clearance
B) Volume of distribution
C) Half-life
D) Elimination rate constant
Rationale: Loading dose is directly calculated using the target plasma concentration
multiplied by the volume of distribution.
Q10. What type of reaction occurs during Phase II drug metabolism?
A) Oxidation
B) Reduction
C) Hydrolysis
D) Conjugation
Rationale: Phase I involves oxidation, reduction, and hydrolysis. Phase II involves
conjugation reactions like glucuronidation to make the drug more polar for excretion.
Q11. Stimulation of alpha-1 adrenergic receptors results in which physiological
action?
A) Bronchodilation
B) Vasoconstriction
C) Bradycardia
D) Increased GI motility
Rationale: Alpha-1 receptors are located on vascular smooth muscle, and their
activation leads to smooth muscle contraction and vasoconstriction.
, 4|Page
Q12. Which drug acts as a selective beta-1 adrenergic antagonist?
A) Propanolol
B) Metoprolol
C) Albuterol
D) Labatalol
Rationale: Metoprolol is a cardioselective beta-blocker that targets beta-1 receptors
primarily found in heart tissue.
Q13. What is the mechanism of action of pilocarpine?
A) Acetylcholinesterase inhibitor
B) Direct muscarinic agonist
C) Nicotinic antagonist
D) Adrenergic agonist
Rationale: Pilocarpine directly stimulates muscarinic acetylcholine receptors,
commonly used to lower intraocular pressure in glaucoma.
Q14. Activation of which receptor subtype is responsible for albuterol-induced
bronchodilation?
A) Alpha-2
B) Beta-1
C) Beta-2
D) Muscarinic-3
Rationale: Beta-2 adrenergic receptors relax smooth muscle in the airways, making
agonists highly effective for asthma.
Q15. What severe adverse effect can occur if a patient taking an MAO inhibitor
consumes foods rich in tyramine?
A) Profound hypotension
B) Hypertensive crisis
C) Respiratory depression
D) Hemolytic anemia
Rationale: Tyramine displaces norepinephrine into synaptic clefts; when MAO is
inhibited, this causes massive sympathetic stimulation and life-threatening
hypertension.
Q16. Which toxic regular effect is associated with an overdose of atropine?
A) Excessive salivation
B) Pupillary constriction
C) Diarrhea
D) Urinary retention
Rationale: Atropine is an anticholinergic block. It shuts down parasympathetic
actions, leading to dry mouth, blurry vision, tachycardia, and urinary retention.
Q17. What is the drug of choice to manage an acute anaphylactic shock reaction?
A) Norepinephrine
B) Epinephrine
C) Dopamine
D) Isoproterenol
Rationale: Epinephrine acts on alpha-1 (vasoconstriction), beta-1 (cardiac output),
and beta-2 (bronchodilation) receptors, reversing all major features of anaphylaxis.
Q18. What is the mechanism of action of physostigmine?
A) Reversible acetylcholinesterase inhibitor
